Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-05-24

AUTHORS

Y.-A. Que, H. Lazar, M. Wolff, B. François, P.-F. Laterre, E. Mercier, J. Garbino, J.-L. Pagani, J.-P. Revelly, E. Mus, A. Perez, M. Tamm, J.-J. Rouby, Q. Lu, J. Chastre, P. Eggimann

ABSTRACT

The fully human anti-lipopolysaccharide (LPS) immunoglobulin M (IgM) monoclonal antibody panobacumab was developed as an adjunctive immunotherapy for the treatment of O11 serotype Pseudomonas aeruginosa infections. We evaluated the potential clinical efficacy of panobacumab in the treatment of nosocomial pneumonia. We performed a post-hoc analysis of a multicenter phase IIa trial (NCT00851435) designed to prospectively evaluate the safety and pharmacokinetics of panobacumab. Patients treated with panobacumab (n = 17), including 13 patients receiving the full treatment (three doses of 1.2 mg/kg), were compared to 14 patients who did not receive the antibody. Overall, the 17 patients receiving panobacumab were more ill. They were an average of 72 years old [interquartile range (IQR): 64–79] versus an average of 50 years old (IQR: 30–73) (p = 0.024) and had Acute Physiology and Chronic Health Evaluation II (APACHE II) scores of 17 (IQR: 16–22) versus 15 (IQR: 10–19) (p = 0.043). Adjunctive immunotherapy resulted in an improved clinical outcome in the group receiving the full three-course panobacumab treatment, with a resolution rate of 85 % (11/13) versus 64 % (9/14) (p = 0.048). The Kaplan–Meier survival curve showed a statistically significantly shorter time to clinical resolution in this group of patients (8.0 [IQR: 7.0–11.5] versus 18.5 [IQR: 8–30] days in those who did not receive the antibody; p = 0.004). Panobacumab adjunctive immunotherapy may improve clinical outcome in a shorter time if patients receive the full treatment (three doses). These preliminary results suggest that passive immunotherapy targeting LPS may be a complementary strategy for the treatment of nosocomial O11 P. aeruginosa pneumonia. More... »

PAGES

1861-1867

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10096-014-2156-1

DOI

http://dx.doi.org/10.1007/s10096-014-2156-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030374277

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24859907


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Bacterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross Infection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin M", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunologic Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pneumonia, Bacterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pseudomonas aeruginosa", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serogroup", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.414250.6", 
          "name": [
            "Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Que", 
        "givenName": "Y.-A.", 
        "id": "sg:person.01106457060.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106457060.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kenta Biotech, Schlieren, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Kenta Biotech, Schlieren, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lazar", 
        "givenName": "H.", 
        "id": "sg:person.01140423300.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140423300.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "R\u00e9animation M\u00e9dicale et Infectieuse, Hopital Bichat-Claude Bernard, AP-HP, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "R\u00e9animation M\u00e9dicale et Infectieuse, Hopital Bichat-Claude Bernard, AP-HP, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wolff", 
        "givenName": "M.", 
        "id": "sg:person.01006646252.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006646252.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Intensive Care Unit, CIC-P 0801 Inserm, CHU Dupuytren, Limoges, France", 
          "id": "http://www.grid.ac/institutes/grid.412212.6", 
          "name": [
            "Intensive Care Unit, CIC-P 0801 Inserm, CHU Dupuytren, Limoges, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fran\u00e7ois", 
        "givenName": "B.", 
        "id": "sg:person.01117500047.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117500047.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Intensive Care Unit, Saint-Luc University Hospital, UCL, Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.48769.34", 
          "name": [
            "Intensive Care Unit, Saint-Luc University Hospital, UCL, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laterre", 
        "givenName": "P.-F.", 
        "id": "sg:person.01103401337.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103401337.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de R\u00e9animation Polyvalente and CRICS Network, CHRU de Tours, Tours, France", 
          "id": "http://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Service de R\u00e9animation Polyvalente and CRICS Network, CHRU de Tours, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mercier", 
        "givenName": "E.", 
        "id": "sg:person.0741762205.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741762205.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.150338.c", 
          "name": [
            "Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garbino", 
        "givenName": "J.", 
        "id": "sg:person.0700430756.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700430756.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.414250.6", 
          "name": [
            "Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pagani", 
        "givenName": "J.-L.", 
        "id": "sg:person.01346365275.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346365275.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.414250.6", 
          "name": [
            "Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Revelly", 
        "givenName": "J.-P.", 
        "id": "sg:person.0725460421.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725460421.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kenta Biotech, Schlieren, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Kenta Biotech, Schlieren, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mus", 
        "givenName": "E.", 
        "id": "sg:person.01043752442.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043752442.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kenta Biotech, Schlieren, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Kenta Biotech, Schlieren, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perez", 
        "givenName": "A.", 
        "id": "sg:person.01174547767.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174547767.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pneumonia Clinic, University Hospital Basel, Basel, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.410567.1", 
          "name": [
            "Pneumonia Clinic, University Hospital Basel, Basel, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tamm", 
        "givenName": "M.", 
        "id": "sg:person.01112036134.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112036134.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "R\u00e9animation Polyvalente, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris, UPMC Paris 6, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "R\u00e9animation Polyvalente, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris, UPMC Paris 6, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rouby", 
        "givenName": "J.-J.", 
        "id": "sg:person.01011313221.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011313221.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "R\u00e9animation Polyvalente, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris, UPMC Paris 6, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "R\u00e9animation Polyvalente, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris, UPMC Paris 6, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "Q.", 
        "id": "sg:person.0743200021.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743200021.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de R\u00e9animation M\u00e9dicale, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chastre", 
        "givenName": "J.", 
        "id": "sg:person.0714077601.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714077601.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.414250.6", 
          "name": [
            "Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eggimann", 
        "givenName": "P.", 
        "id": "sg:person.0725135730.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725135730.99"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00134-012-2695-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002785702", 
          "https://doi.org/10.1007/s00134-012-2695-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01709751", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052044737", 
          "https://doi.org/10.1007/bf01709751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc13697", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016904789", 
          "https://doi.org/10.1186/cc13697"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10238-005-0070-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010156051", 
          "https://doi.org/10.1007/s10238-005-0070-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-012-1758-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020359417", 
          "https://doi.org/10.1007/s10096-012-1758-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-05-24", 
    "datePublishedReg": "2014-05-24", 
    "description": "The fully human anti-lipopolysaccharide (LPS) immunoglobulin M (IgM) monoclonal antibody panobacumab was developed as an adjunctive immunotherapy for the treatment of O11 serotype Pseudomonas aeruginosa infections. We evaluated the potential clinical efficacy of panobacumab in the treatment of nosocomial pneumonia. We performed a post-hoc analysis of a multicenter phase IIa trial (NCT00851435) designed to prospectively evaluate the safety and pharmacokinetics of panobacumab. Patients treated with panobacumab (n\u2009=\u200917), including 13 patients receiving the full treatment (three doses of 1.2\u00a0mg/kg), were compared to 14 patients who did not receive the antibody. Overall, the 17 patients receiving panobacumab were more ill. They were an average of 72\u00a0years old [interquartile range (IQR): 64\u201379] versus an average of 50\u00a0years old (IQR: 30\u201373) (p\u2009=\u20090.024) and had Acute Physiology and Chronic Health Evaluation II (APACHE II) scores of 17 (IQR: 16\u201322) versus 15 (IQR: 10\u201319) (p\u2009=\u20090.043). Adjunctive immunotherapy resulted in an improved clinical outcome in the group receiving the full three-course panobacumab treatment, with a resolution rate of 85\u00a0% (11/13) versus 64\u00a0% (9/14) (p\u2009=\u20090.048). The Kaplan\u2013Meier survival curve showed a statistically significantly shorter time to clinical resolution in this group of patients (8.0 [IQR: 7.0\u201311.5] versus 18.5 [IQR: 8\u201330] days in those who did not receive the antibody; p\u2009=\u20090.004). Panobacumab adjunctive immunotherapy may improve clinical outcome in a shorter time if patients receive the full treatment (three doses). These preliminary results suggest that passive immunotherapy targeting LPS may be a complementary strategy for the treatment of nosocomial O11 P. aeruginosa pneumonia.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10096-014-2156-1", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1093599", 
        "issn": [
          "0934-9723", 
          "1435-4373"
        ], 
        "name": "European Journal of Clinical Microbiology & Infectious Diseases", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "keywords": [
      "adjunctive immunotherapy", 
      "aeruginosa pneumonia", 
      "clinical outcomes", 
      "Chronic Health Evaluation II score", 
      "Kaplan-Meier survival curves", 
      "phase IIa trial", 
      "Pseudomonas aeruginosa pneumonia", 
      "P. aeruginosa pneumonia", 
      "group of patients", 
      "improved clinical outcomes", 
      "potential clinical efficacy", 
      "Pseudomonas aeruginosa infection", 
      "Acute Physiology", 
      "nosocomial pneumonia", 
      "IIa trial", 
      "II score", 
      "clinical resolution", 
      "clinical efficacy", 
      "passive immunotherapy", 
      "panobacumab", 
      "aeruginosa infection", 
      "immunotherapy", 
      "resolution rate", 
      "patients", 
      "survival curves", 
      "pneumonia", 
      "treatment", 
      "outcomes", 
      "full treatment", 
      "group", 
      "pharmacokinetics", 
      "years", 
      "LPS", 
      "infection", 
      "trials", 
      "antibodies", 
      "efficacy", 
      "complementary strategies", 
      "short time", 
      "scores", 
      "safety", 
      "preliminary results", 
      "physiology", 
      "average", 
      "assessment", 
      "rate", 
      "time", 
      "strategies", 
      "curves", 
      "analysis", 
      "results", 
      "resolution"
    ], 
    "name": "Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia", 
    "pagination": "1861-1867", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030374277"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10096-014-2156-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24859907"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10096-014-2156-1", 
      "https://app.dimensions.ai/details/publication/pub.1030374277"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_640.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10096-014-2156-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10096-014-2156-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10096-014-2156-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10096-014-2156-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10096-014-2156-1'


 

This table displays all metadata directly associated to this object as RDF triples.

332 TRIPLES      21 PREDICATES      99 URIs      86 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10096-014-2156-1 schema:about N1538c0195d1741d1add66e7c0be2aa72
2 N2464b6a8969a495094c6197cb3053741
3 N266ecc1927634e5fba63d55fb90cf0ee
4 N46a7cab46c9741ceb92d350d8f3f3088
5 N54442438cf9e4a83a284d53e6b71e8c9
6 N8e9a6b8876f94e889af95724958b1352
7 N9842f5c407df461eaae749f10b17648b
8 N99279acae11e4eaa834c9cb96eb1bb80
9 Na96f8699696845b1b0eb815198a0cbdd
10 Nb4e6a5154478408a9ea6340f5dcfd2c2
11 Nb89b2924c2694befb3fbee7cdda6d6e5
12 Nc3199747895844b5bb7ad7f15b3b2fb4
13 Nc66c0371dee54da3bc4851e3cb4775da
14 Nd9df849dd4254581a1a15134aafbcf27
15 Ne132ccbfaeda4268be7563142407783e
16 Nf22c906e0eff44f3a5562a2c3eb47023
17 Nfa170c6b31b542a99d2e431c5f65211f
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author Nce2c26e38a6548658e77d1d2cef2e5b3
21 schema:citation sg:pub.10.1007/bf01709751
22 sg:pub.10.1007/s00134-012-2695-9
23 sg:pub.10.1007/s10096-012-1758-8
24 sg:pub.10.1007/s10238-005-0070-7
25 sg:pub.10.1186/cc13697
26 schema:datePublished 2014-05-24
27 schema:datePublishedReg 2014-05-24
28 schema:description The fully human anti-lipopolysaccharide (LPS) immunoglobulin M (IgM) monoclonal antibody panobacumab was developed as an adjunctive immunotherapy for the treatment of O11 serotype Pseudomonas aeruginosa infections. We evaluated the potential clinical efficacy of panobacumab in the treatment of nosocomial pneumonia. We performed a post-hoc analysis of a multicenter phase IIa trial (NCT00851435) designed to prospectively evaluate the safety and pharmacokinetics of panobacumab. Patients treated with panobacumab (n = 17), including 13 patients receiving the full treatment (three doses of 1.2 mg/kg), were compared to 14 patients who did not receive the antibody. Overall, the 17 patients receiving panobacumab were more ill. They were an average of 72 years old [interquartile range (IQR): 64–79] versus an average of 50 years old (IQR: 30–73) (p = 0.024) and had Acute Physiology and Chronic Health Evaluation II (APACHE II) scores of 17 (IQR: 16–22) versus 15 (IQR: 10–19) (p = 0.043). Adjunctive immunotherapy resulted in an improved clinical outcome in the group receiving the full three-course panobacumab treatment, with a resolution rate of 85 % (11/13) versus 64 % (9/14) (p = 0.048). The Kaplan–Meier survival curve showed a statistically significantly shorter time to clinical resolution in this group of patients (8.0 [IQR: 7.0–11.5] versus 18.5 [IQR: 8–30] days in those who did not receive the antibody; p = 0.004). Panobacumab adjunctive immunotherapy may improve clinical outcome in a shorter time if patients receive the full treatment (three doses). These preliminary results suggest that passive immunotherapy targeting LPS may be a complementary strategy for the treatment of nosocomial O11 P. aeruginosa pneumonia.
29 schema:genre article
30 schema:isAccessibleForFree true
31 schema:isPartOf N3262e09a927d49c4b85f11800f429c20
32 N8e2bd1d96c24431d9686dce8a909b517
33 sg:journal.1093599
34 schema:keywords Acute Physiology
35 Chronic Health Evaluation II score
36 II score
37 IIa trial
38 Kaplan-Meier survival curves
39 LPS
40 P. aeruginosa pneumonia
41 Pseudomonas aeruginosa infection
42 Pseudomonas aeruginosa pneumonia
43 adjunctive immunotherapy
44 aeruginosa infection
45 aeruginosa pneumonia
46 analysis
47 antibodies
48 assessment
49 average
50 clinical efficacy
51 clinical outcomes
52 clinical resolution
53 complementary strategies
54 curves
55 efficacy
56 full treatment
57 group
58 group of patients
59 immunotherapy
60 improved clinical outcomes
61 infection
62 nosocomial pneumonia
63 outcomes
64 panobacumab
65 passive immunotherapy
66 patients
67 pharmacokinetics
68 phase IIa trial
69 physiology
70 pneumonia
71 potential clinical efficacy
72 preliminary results
73 rate
74 resolution
75 resolution rate
76 results
77 safety
78 scores
79 short time
80 strategies
81 survival curves
82 time
83 treatment
84 trials
85 years
86 schema:name Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia
87 schema:pagination 1861-1867
88 schema:productId N9384b28ad782411fb4d19edf5f76bbde
89 Nc195f744d0b5439caecf7adbf3fae507
90 Nd310a089d793429b826036ee0271253a
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030374277
92 https://doi.org/10.1007/s10096-014-2156-1
93 schema:sdDatePublished 2022-09-02T15:57
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N3e156cc44a034115a337df692531d83e
96 schema:url https://doi.org/10.1007/s10096-014-2156-1
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N0cdc3d5918df4b11b24b8b233d8db370 rdf:first sg:person.0741762205.37
101 rdf:rest Nacac4a4d90c64e3c925567fb750f86c4
102 N1538c0195d1741d1add66e7c0be2aa72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Pseudomonas aeruginosa
104 rdf:type schema:DefinedTerm
105 N244a6a3fd71349cd9dea5699b4d696cf rdf:first sg:person.01346365275.39
106 rdf:rest N6676edeb64fa4dd7a00492d0c98a737b
107 N2464b6a8969a495094c6197cb3053741 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Antibodies, Monoclonal
109 rdf:type schema:DefinedTerm
110 N266ecc1927634e5fba63d55fb90cf0ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Cross Infection
112 rdf:type schema:DefinedTerm
113 N3262e09a927d49c4b85f11800f429c20 schema:volumeNumber 33
114 rdf:type schema:PublicationVolume
115 N3e156cc44a034115a337df692531d83e schema:name Springer Nature - SN SciGraph project
116 rdf:type schema:Organization
117 N46a7cab46c9741ceb92d350d8f3f3088 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Immunoglobulin M
119 rdf:type schema:DefinedTerm
120 N54442438cf9e4a83a284d53e6b71e8c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Male
122 rdf:type schema:DefinedTerm
123 N6676edeb64fa4dd7a00492d0c98a737b rdf:first sg:person.0725460421.52
124 rdf:rest Ne41cf2897f6b49129cf81e163b2f08d6
125 N6b8229c549b24d0fb6b8ce50f18adc43 rdf:first sg:person.01112036134.17
126 rdf:rest Ne7371ce841bb473ba1806f2bb564dc4b
127 N8e2bd1d96c24431d9686dce8a909b517 schema:issueNumber 10
128 rdf:type schema:PublicationIssue
129 N8e9a6b8876f94e889af95724958b1352 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Humans
131 rdf:type schema:DefinedTerm
132 N9384b28ad782411fb4d19edf5f76bbde schema:name dimensions_id
133 schema:value pub.1030374277
134 rdf:type schema:PropertyValue
135 N974396b4220d4bc2a3d3367ee81e41fd rdf:first sg:person.01006646252.99
136 rdf:rest Na1bc483b53a1404ba984e29f39f742e1
137 N9842f5c407df461eaae749f10b17648b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Pneumonia, Bacterial
139 rdf:type schema:DefinedTerm
140 N99279acae11e4eaa834c9cb96eb1bb80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Immunotherapy
142 rdf:type schema:DefinedTerm
143 Na1bc483b53a1404ba984e29f39f742e1 rdf:first sg:person.01117500047.55
144 rdf:rest Ne96c509670bd456286d313b14dcd7b3b
145 Na96f8699696845b1b0eb815198a0cbdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Antibodies, Bacterial
147 rdf:type schema:DefinedTerm
148 Naa548dfd3013496b95c7cf4dae28cfe1 rdf:first sg:person.0714077601.27
149 rdf:rest Ndd04b6c00ad6469d9de3249ecc653b8c
150 Nacac4a4d90c64e3c925567fb750f86c4 rdf:first sg:person.0700430756.85
151 rdf:rest N244a6a3fd71349cd9dea5699b4d696cf
152 Naeb9bb6c44334e929297f5c023aaede3 rdf:first sg:person.01140423300.61
153 rdf:rest N974396b4220d4bc2a3d3367ee81e41fd
154 Nb4e6a5154478408a9ea6340f5dcfd2c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Aged
156 rdf:type schema:DefinedTerm
157 Nb89b2924c2694befb3fbee7cdda6d6e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Middle Aged
159 rdf:type schema:DefinedTerm
160 Nc195f744d0b5439caecf7adbf3fae507 schema:name pubmed_id
161 schema:value 24859907
162 rdf:type schema:PropertyValue
163 Nc3199747895844b5bb7ad7f15b3b2fb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Adult
165 rdf:type schema:DefinedTerm
166 Nc66c0371dee54da3bc4851e3cb4775da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Prospective Studies
168 rdf:type schema:DefinedTerm
169 Nca2c94497aca44158b4c0a6796683e58 rdf:first sg:person.0743200021.09
170 rdf:rest Naa548dfd3013496b95c7cf4dae28cfe1
171 Nce2c26e38a6548658e77d1d2cef2e5b3 rdf:first sg:person.01106457060.32
172 rdf:rest Naeb9bb6c44334e929297f5c023aaede3
173 Nd2b73de81bd3474aa87b015e9c77f850 rdf:first sg:person.01174547767.32
174 rdf:rest N6b8229c549b24d0fb6b8ce50f18adc43
175 Nd310a089d793429b826036ee0271253a schema:name doi
176 schema:value 10.1007/s10096-014-2156-1
177 rdf:type schema:PropertyValue
178 Nd9df849dd4254581a1a15134aafbcf27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Immunologic Factors
180 rdf:type schema:DefinedTerm
181 Ndd04b6c00ad6469d9de3249ecc653b8c rdf:first sg:person.0725135730.99
182 rdf:rest rdf:nil
183 Ne132ccbfaeda4268be7563142407783e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Treatment Outcome
185 rdf:type schema:DefinedTerm
186 Ne41cf2897f6b49129cf81e163b2f08d6 rdf:first sg:person.01043752442.30
187 rdf:rest Nd2b73de81bd3474aa87b015e9c77f850
188 Ne7371ce841bb473ba1806f2bb564dc4b rdf:first sg:person.01011313221.01
189 rdf:rest Nca2c94497aca44158b4c0a6796683e58
190 Ne96c509670bd456286d313b14dcd7b3b rdf:first sg:person.01103401337.27
191 rdf:rest N0cdc3d5918df4b11b24b8b233d8db370
192 Nf22c906e0eff44f3a5562a2c3eb47023 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Serogroup
194 rdf:type schema:DefinedTerm
195 Nfa170c6b31b542a99d2e431c5f65211f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Female
197 rdf:type schema:DefinedTerm
198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
199 schema:name Medical and Health Sciences
200 rdf:type schema:DefinedTerm
201 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
202 schema:name Clinical Sciences
203 rdf:type schema:DefinedTerm
204 sg:journal.1093599 schema:issn 0934-9723
205 1435-4373
206 schema:name European Journal of Clinical Microbiology & Infectious Diseases
207 schema:publisher Springer Nature
208 rdf:type schema:Periodical
209 sg:person.01006646252.99 schema:affiliation grid-institutes:grid.411119.d
210 schema:familyName Wolff
211 schema:givenName M.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006646252.99
213 rdf:type schema:Person
214 sg:person.01011313221.01 schema:affiliation grid-institutes:grid.411439.a
215 schema:familyName Rouby
216 schema:givenName J.-J.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011313221.01
218 rdf:type schema:Person
219 sg:person.01043752442.30 schema:affiliation grid-institutes:None
220 schema:familyName Mus
221 schema:givenName E.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043752442.30
223 rdf:type schema:Person
224 sg:person.01103401337.27 schema:affiliation grid-institutes:grid.48769.34
225 schema:familyName Laterre
226 schema:givenName P.-F.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103401337.27
228 rdf:type schema:Person
229 sg:person.01106457060.32 schema:affiliation grid-institutes:grid.414250.6
230 schema:familyName Que
231 schema:givenName Y.-A.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106457060.32
233 rdf:type schema:Person
234 sg:person.01112036134.17 schema:affiliation grid-institutes:grid.410567.1
235 schema:familyName Tamm
236 schema:givenName M.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112036134.17
238 rdf:type schema:Person
239 sg:person.01117500047.55 schema:affiliation grid-institutes:grid.412212.6
240 schema:familyName François
241 schema:givenName B.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117500047.55
243 rdf:type schema:Person
244 sg:person.01140423300.61 schema:affiliation grid-institutes:None
245 schema:familyName Lazar
246 schema:givenName H.
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140423300.61
248 rdf:type schema:Person
249 sg:person.01174547767.32 schema:affiliation grid-institutes:None
250 schema:familyName Perez
251 schema:givenName A.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174547767.32
253 rdf:type schema:Person
254 sg:person.01346365275.39 schema:affiliation grid-institutes:grid.414250.6
255 schema:familyName Pagani
256 schema:givenName J.-L.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346365275.39
258 rdf:type schema:Person
259 sg:person.0700430756.85 schema:affiliation grid-institutes:grid.150338.c
260 schema:familyName Garbino
261 schema:givenName J.
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700430756.85
263 rdf:type schema:Person
264 sg:person.0714077601.27 schema:affiliation grid-institutes:grid.411439.a
265 schema:familyName Chastre
266 schema:givenName J.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714077601.27
268 rdf:type schema:Person
269 sg:person.0725135730.99 schema:affiliation grid-institutes:grid.414250.6
270 schema:familyName Eggimann
271 schema:givenName P.
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725135730.99
273 rdf:type schema:Person
274 sg:person.0725460421.52 schema:affiliation grid-institutes:grid.414250.6
275 schema:familyName Revelly
276 schema:givenName J.-P.
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725460421.52
278 rdf:type schema:Person
279 sg:person.0741762205.37 schema:affiliation grid-institutes:grid.411167.4
280 schema:familyName Mercier
281 schema:givenName E.
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741762205.37
283 rdf:type schema:Person
284 sg:person.0743200021.09 schema:affiliation grid-institutes:grid.411439.a
285 schema:familyName Lu
286 schema:givenName Q.
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743200021.09
288 rdf:type schema:Person
289 sg:pub.10.1007/bf01709751 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052044737
290 https://doi.org/10.1007/bf01709751
291 rdf:type schema:CreativeWork
292 sg:pub.10.1007/s00134-012-2695-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002785702
293 https://doi.org/10.1007/s00134-012-2695-9
294 rdf:type schema:CreativeWork
295 sg:pub.10.1007/s10096-012-1758-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020359417
296 https://doi.org/10.1007/s10096-012-1758-8
297 rdf:type schema:CreativeWork
298 sg:pub.10.1007/s10238-005-0070-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010156051
299 https://doi.org/10.1007/s10238-005-0070-7
300 rdf:type schema:CreativeWork
301 sg:pub.10.1186/cc13697 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016904789
302 https://doi.org/10.1186/cc13697
303 rdf:type schema:CreativeWork
304 grid-institutes:None schema:alternateName Kenta Biotech, Schlieren, Switzerland
305 schema:name Kenta Biotech, Schlieren, Switzerland
306 rdf:type schema:Organization
307 grid-institutes:grid.150338.c schema:alternateName Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
308 schema:name Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
309 rdf:type schema:Organization
310 grid-institutes:grid.410567.1 schema:alternateName Pneumonia Clinic, University Hospital Basel, Basel, Switzerland
311 schema:name Pneumonia Clinic, University Hospital Basel, Basel, Switzerland
312 rdf:type schema:Organization
313 grid-institutes:grid.411119.d schema:alternateName Réanimation Médicale et Infectieuse, Hopital Bichat-Claude Bernard, AP-HP, Paris, France
314 schema:name Réanimation Médicale et Infectieuse, Hopital Bichat-Claude Bernard, AP-HP, Paris, France
315 rdf:type schema:Organization
316 grid-institutes:grid.411167.4 schema:alternateName Service de Réanimation Polyvalente and CRICS Network, CHRU de Tours, Tours, France
317 schema:name Service de Réanimation Polyvalente and CRICS Network, CHRU de Tours, Tours, France
318 rdf:type schema:Organization
319 grid-institutes:grid.411439.a schema:alternateName Réanimation Polyvalente, Département d’Anesthésie-Réanimation, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, UPMC Paris 6, Paris, France
320 Service de Réanimation Médicale, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
321 schema:name Réanimation Polyvalente, Département d’Anesthésie-Réanimation, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, UPMC Paris 6, Paris, France
322 Service de Réanimation Médicale, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
323 rdf:type schema:Organization
324 grid-institutes:grid.412212.6 schema:alternateName Intensive Care Unit, CIC-P 0801 Inserm, CHU Dupuytren, Limoges, France
325 schema:name Intensive Care Unit, CIC-P 0801 Inserm, CHU Dupuytren, Limoges, France
326 rdf:type schema:Organization
327 grid-institutes:grid.414250.6 schema:alternateName Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland
328 schema:name Adult Critical Care Service, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland
329 rdf:type schema:Organization
330 grid-institutes:grid.48769.34 schema:alternateName Intensive Care Unit, Saint-Luc University Hospital, UCL, Brussels, Belgium
331 schema:name Intensive Care Unit, Saint-Luc University Hospital, UCL, Brussels, Belgium
332 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...